Staber PB, Jurczak W, Greil R, Vucinic V, et al. Tafasitamab combined with idelalisib or venetoclax in patients with CLL previously treated with a BTK inhibitor. Leuk Lymphoma 2021;62:3440-3451.
PMID: 34414843